サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1494469

アジア太平洋の医薬品販売受託機関市場の2030年予測-地域別分析-サービス、モジュール、治療分野、エンドユーザー別

Asia Pacific Pharmaceutical Contract Sales Organizations Market Forecast to 2030 - Regional Analysis - by Services, Modules, Therapeutic Area, and End User

出版日
ページ情報
英文 88 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
アジア太平洋の医薬品販売受託機関市場の2030年予測-地域別分析-サービス、モジュール、治療分野、エンドユーザー別
出版日: 2024年04月05日
発行: The Insight Partners
ページ情報: 英文 88 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋の医薬品販売受託機関市場は、2022年の17億748万米ドルから2030年には36億4,688万米ドルに成長すると予測されています。2022～2030年のCAGRは10.0%を記録すると推定されます。

遠隔医療と遠隔ディテーリング利用の増加がアジア太平洋医薬品販売受託機関市場を牽引

遠隔医療と遠隔ディテーリング利用の増加は、医薬品販売受託機関（CSO）市場に新たな機会をもたらします。デジタル医療技術の変革的影響は、患者と医師の相互作用を再定義し、医薬品販売の力学に革命をもたらしました。遠隔医療は、バーチャルな診察や契約を促進する能力を備えており、CSOが適応し、革新するための肥沃な土壌を作り出しています。製品情報を伝達し、医療専門家を関与させるためにデジタルチャネルを使用する遠隔ディテーリングは、CSOがリーチを拡大するための戦略的手段となります。この戦略的変化は、製薬業界が市場の複雑さを克服するために積極的に取り組んでいることを浮き彫りにしています。CSOと協力することで、製薬企業は専門の営業担当者にアクセスすることができ、外部の専門知識を活用して市場浸透率を高め、営業効果を向上させることができます。この協業モデルを通じて、製薬企業は業務を効率化し、研究開発などの主要機能に集中する一方、CSOの特殊な知識を活用して製品の市場性を高めることができます。製薬企業とCSOの協力関係の高まりは、適応への献身と、競争の激しい製薬業界における発展途上の力学を深く理解していることを示しています。また、リソースの最適化に対する微妙な理解も示しています。この互恵的なパートナーシップは収益の最大化を可能にし、長期的な成功のためには適応力と集中的な市場戦略が不可欠な市場に製薬企業を戦略的に位置づけています。

アジア太平洋医薬品販売受託機関市場概要

アジア太平洋の医薬品販売受託機関市場は、費用対効果の高い販売・マーケティングソリューションに対する需要の高まりにより、近年大きな成長を遂げています。製薬会社は、中国、インド、日本などの国々で医療製品の需要が大きいにもかかわらず、多様で遠隔地にある市場への参入という課題に直面しています。営業・マーケティング機能をCSOにアウトソーシングすることで、企業は大規模なインフラや人的投資をすることなく、専門チームの専門知識を活用することができます。さらに、アジア太平洋における慢性疾患の増加や高齢化の進展も、医薬品販売受託機関市場の拡大に寄与しています。

デジタル技術の利用可能性と導入が進み、多数のデータソースに簡単にアクセスできるようになったことで、医薬品CSOはリアルタイムのデータを収集・分析できるようになり、その結果、実行可能な洞察の活用で顧客を支援しています。2023年4月、SANOFI Chinaは、進化するダイナミックなビジネスモデルに適応する拡大性のある商用オムニプレゼンスCRMソリューションを採用し、デジタルトランスフォーメーションを加速させ、イノベーションに向けた取り組みを継続できるようにしました。Omnipresence CRMは、高度な分析、データソース、機械学習を使用して洞察を生成し、より良い意思決定をサポートし、コマーシャルチームが俊敏性を向上させて結果をスピードアップするための新たな機会を創出します。

アジア太平洋の医薬品販売受託機関市場の収益と2030年までの予測（金額）

アジア太平洋の医薬品販売受託機関市場のセグメンテーション

アジア太平洋の医薬品販売受託機関市場は、サービス、モジュール、治療分野、エンドユーザー、国別に区分されます。

サービス別に見ると、アジア太平洋の医薬品販売受託機関市場は、商用サービスと非商用サービスに二分されます。2022年のアジア太平洋医薬品販売受託機関市場では、商業サービスセグメントが大きなシェアを占めています。

モジュール別に見ると、アジア太平洋の医薬品販売受託機関市場はシンジケートモジュールと専用モジュールに二分されます。2022年のアジア太平洋医薬品販売受託機関市場では、シンジケートモジュールセグメントが大きなシェアを占めています。

治療分野別に見ると、アジア太平洋の医薬品販売受託機関市場は、心血管疾患、がん、代謝疾患、神経疾患、整形外科疾患、感染症、その他に区分されます。2022年のアジア太平洋医薬品販売受託機関市場では、がんセグメントが最大のシェアを占めています。

エンドユーザー別に見ると、アジア太平洋の医薬品販売会社市場はバイオ製薬会社と製薬会社に二分されます。2022年のアジア太平洋の医薬品販売受託機関市場では、製薬会社セグメントが大きなシェアを占めています。

国別に見ると、アジア太平洋の医薬品販売契約市場は、中国、日本、インド、オーストラリア、韓国、その他のアジア太平洋に区分されます。中国が2022年のアジア太平洋医薬品販売受託機関市場を独占しました。

Aenova Holding GmbH、CMIC Holdings Co Ltd、EPS Holdings Inc、IQVIA Holdings Inc、Mednext Pharmaceuticals Pvt Ltd、Pfizer Inc、Syneos Health Incは、アジア太平洋の医薬品販売契約市場で事業を展開している大手企業の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブ概要

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋医薬品販売受託機関市場情勢

  • イントロダクション
  • PEST分析
    • アジア太平洋のPEST分析

第5章 アジア太平洋医薬品販売受託機関市場：主要産業力学

  • 市場促進要因
    • デジタル技術の統合の進展
    • 製薬会社による製品販売拡大への関心の高まり
  • 主要市場抑制要因
    • アウトソーシングに伴う品質問題
  • 主要市場機会
    • 遠隔医療と遠隔明細書作成の利用の増加
  • 今後の主要動向
    • 新興市場での拡大
  • 影響分析

第6章 医薬品販売受託機関市場：アジア太平洋市場分析

  • アジア太平洋の医薬品販売受託機関市場売上高、2022～2030年

第7章 アジア太平洋医薬品販売受託機関市場：サービス別収益と2030年までの予測

  • イントロダクション
  • アジア太平洋医薬品販売受託機関市場、サービス別、2022年・2030年、売上高シェア（%）
  • 商用サービス
  • 非商用サービス

第8章 アジア太平洋医薬品販売受託機関市場：モジュール別収益と2030年までの予測

  • イントロダクション
  • アジア太平洋医薬品販売受託機関市場、モジュール別、2022年・2030年、売上高シェア（%）
  • 協調モジュール
  • 専用モジュール

第9章 アジア太平洋医薬品販売受託機関市場：治療分野別収益と2030年までの予測

  • イントロダクション
  • アジア太平洋医薬品販売受託機関市場、治療分野別、2022年・2030年、売上高シェア（%）
  • 心血管疾患
  • がん
  • 代謝疾患
  • 神経疾患
  • 整形外科疾患
  • 感染症
  • その他

第10章 アジア太平洋医薬品販売受託機関市場：エンドユーザー別収益と2030年までの予測

  • イントロダクション
  • アジア太平洋医薬品販売受託機関市場、エンドユーザー別、2022年・2030年、売上高シェア（%）
  • バイオ医薬品企業
  • 製薬企業

第11章 アジア太平洋医薬品販売受託機関市場：国別分析

  • アジア太平洋
      • アジア太平洋の医薬品販売受託機関市場：国別
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • その他のアジア太平洋

第12章 医薬品販売受託機関市場-業界情勢

  • イントロダクション
  • 成長戦略
    • 概要

第13章 企業プロファイル

  • CMIC Holdings Co Ltd
  • EPS Holdings Inc
  • IQVIA Holdings Inc
  • Syneos Health Inc
  • Mednext Pharmaceuticals Pvt Ltd
  • Aenova Holding GmbH
  • Pfizer Inc

第14章 付録

図表

List Of Tables

  • Table 1. Asia Pacific Pharmaceutical Contract Sales Organizations Market Segmentation
  • Table 2. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market
  • Table 27. Glossary of Terms, Asia Pacific Pharmaceutical Contract Sales Organizations Market

List Of Figures

  • Figure 1. Asia Pacific Pharmaceutical Contract Sales Organizations Market Segmentation, By Country
  • Figure 2. Asia Pacific - PEST Analysis
  • Figure 3. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
  • Figure 7. Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Non-Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
  • Figure 10. Syndicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Dedicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
  • Figure 13. Cardiovascular Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Oncology: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Metabolic Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Neurology: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Orthopedic Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Infectious Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
  • Figure 21. Biopharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Pharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 24. Asia Pacific Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)
  • Figure 25. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
目次
Product Code: BMIRE00030019

The Asia Pacific pharmaceutical contract sales organizations market is expected to grow from US$ 1,707.48 million in 2022 to US$ 3,646.88 million by 2030. It is estimated to record a CAGR of 10.0% from 2022 to 2030.

Rising Use of Telemedicine and Remote Detailing Drives Asia Pacific Pharmaceutical Contract Sales Organizations Market

The increasing use of telemedicine and remote detailing leads to new opportunities for the pharmaceutical contract sales organization (CSO) market. The transformative influence of digital health technologies has redefined patient-doctor interactions and revolutionized the dynamics of pharmaceutical sales. With its capacity to facilitate virtual consultations and engagements, telemedicine creates a fertile ground for CSOs to adapt and innovate. Remote detailing, which involves using digital channels to communicate product information and engage healthcare professionals, becomes a strategic avenue for CSOs to extend their reach. This strategic change highlights the pharmaceutical industry's proactive approach to navigating the market's complexity. By working with CSOs, these businesses can access specialist sales personnel, leveraging outside expertise to increase market penetration and improve sales effectiveness. Through this collaborative model, pharmaceutical companies may streamline their operations and concentrate on key capabilities like research and development while utilizing the specific knowledge of CSOs to increase the marketability of their products. The rising cooperation between pharmaceutical corporations and CSOs demonstrates a dedication to adaptation and a profound grasp of the developing dynamics within the very competitive pharmaceutical industry. It also displays a nuanced understanding of resource optimization. This mutually beneficial partnership makes revenue maximization possible and strategically places pharmaceutical firms in a market where adaptability and focused market strategies are essential for long-term success.

Asia Pacific Pharmaceutical Contract Sales Organizations Market Overview

The Asia Pacific pharmaceutical contract sales organization market has experienced significant growth in recent years owing to the elevated demand for cost-effective sales and marketing solutions. Pharmaceutical companies face the challenge of reaching diverse and remote markets in countries such as China, India, and Japan, despite a significant demand for healthcare products in these countries. By outsourcing sales and marketing functions to CSOs, the companies can benefit from the expertise of specialized teams without the need for extensive infrastructure and personnel investments. Furthermore, the rise in chronic diseases and the growing aging population in the Asia Pacific region have also contributed to the expansion of the pharmaceutical contract sales organization market.

The increasing availability and adoption of digital technologies, and easy access to a large number of data sources allow pharmaceutical CSOs to gather and analyze real-time data, thereby assisting their clients with the use of actionable insights. In April 2023, SANOFI China adopted a scalable, commercial omnipresence CRM solution that would adapt to its evolving, dynamic business model, thereby accelerating digital transformation and allowing the company to continue working toward innovation. Omnipresence CRM uses advanced analytics, data sources, and machine learning to generate insights, support better decision-making, and create new opportunities for commercial teams to speed up results with increased agility.

Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Pharmaceutical Contract Sales Organizations Market Segmentation

The Asia Pacific pharmaceutical contract sales organizations market is segmented into services, modules, therapeutic area, end user, and country.

Based on services, the Asia Pacific pharmaceutical contract sales organizations market is bifurcated into commercial services and non-commercial services. The commercial services segment held a larger share of the Asia Pacific pharmaceutical contract sales organizations market in 2022.

Based on modules, the Asia Pacific pharmaceutical contract sales organizations market is bifurcated into syndicated modules and dedicated modules. The syndicated modules segment held a larger share of the Asia Pacific pharmaceutical contract sales organizations market in 2022.

Based on therapeutic area, the Asia Pacific pharmaceutical contract sales organizations market is segmented into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others. The oncology segment held the largest share of the Asia Pacific pharmaceutical contract sales organizations market in 2022.

Based on end user, the Asia Pacific pharmaceutical contract sales organizations market is bifurcated into biopharmaceutical companies and pharmaceutical companies. The pharmaceutical companies segment held a larger share of the Asia Pacific pharmaceutical contract sales organizations market in 2022.

Based on country, the Asia Pacific pharmaceutical contract sales organizations market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific pharmaceutical contract sales organizations market in 2022.

Aenova Holding GmbH, CMIC Holdings Co Ltd, EPS Holdings Inc, IQVIA Holdings Inc, Mednext Pharmaceuticals Pvt Ltd, Pfizer Inc, and Syneos Health Inc are some of the leading companies operating in the Asia Pacific pharmaceutical contract sales organizations market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Pharmaceutical Contract Sales Organizations Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Asia Pacific PEST Analysis

5. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Integration of Digital Technologies
    • 5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products
  • 5.2 Key Market Restraints
    • 5.2.1 Quality Issues Associated with Outsourcing
  • 5.3 Key Market Opportunities
    • 5.3.1 Rising Use of Telemedicine and Remote Detailing
  • 5.4 Key Future Trends
    • 5.4.1 Expansion in Emerging Markets
  • 5.5 Impact Analysis:

6. Pharmaceutical Contract Sales Organizations Market - Asia Pacific Market Analysis

  • 6.1 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services

  • 7.1 Overview
  • 7.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
  • 7.3 Commercial Services
    • 7.3.1 Overview
    • 7.3.2 Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Non-Commercial Services
    • 7.4.1 Overview
    • 7.4.2 Non-Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules

  • 8.1 Overview
  • 8.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
  • 8.3 Syndicated Modules
    • 8.3.1 Overview
    • 8.3.2 Syndicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Dedicated Modules
    • 8.4.1 Overview
    • 8.4.2 Dedicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area

  • 9.1 Overview
  • 9.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
  • 9.3 Cardiovascular Disorders
    • 9.3.1 Overview
    • 9.3.2 Cardiovascular Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Oncology
    • 9.4.1 Overview
    • 9.4.2 Oncology: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Metabolic Disorders
    • 9.5.1 Overview
    • 9.5.2 Metabolic Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Neurology
    • 9.6.1 Overview
    • 9.6.2 Neurology: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.7 Orthopaedic Diseases
    • 9.7.1 Overview
    • 9.7.2 Orthopedic Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.8 Infectious Diseases
    • 9.8.1 Overview
    • 9.8.2 Infectious Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.9 Others
    • 9.9.1 Overview
    • 9.9.2 Others: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User

  • 10.1 Overview
  • 10.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
  • 10.3 Biopharmaceutical Companies
    • 10.3.1 Overview
    • 10.3.2 Biopharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Pharmaceutical Companies
    • 10.4.1 Overview
    • 10.4.2 Pharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Country Analysis

  • 11.1 Asia Pacific
      • 11.1.1.1 Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Country
      • 11.1.1.2 China
        • 11.1.1.2.1 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.2.2 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
        • 11.1.1.2.3 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
        • 11.1.1.2.4 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
        • 11.1.1.2.5 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.3 Japan
        • 11.1.1.3.1 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.3.2 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
        • 11.1.1.3.3 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
        • 11.1.1.3.4 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
        • 11.1.1.3.5 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.4 India
        • 11.1.1.4.1 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.4.2 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
        • 11.1.1.4.3 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
        • 11.1.1.4.4 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
        • 11.1.1.4.5 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.5 Australia
        • 11.1.1.5.1 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.5.2 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
        • 11.1.1.5.3 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
        • 11.1.1.5.4 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
        • 11.1.1.5.5 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.6 South Korea
        • 11.1.1.6.1 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.6.2 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
        • 11.1.1.6.3 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
        • 11.1.1.6.4 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
        • 11.1.1.6.5 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.7 Rest of Asia Pacific
        • 11.1.1.7.1 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.7.2 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
        • 11.1.1.7.3 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
        • 11.1.1.7.4 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
        • 11.1.1.7.5 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies
    • 12.2.1 Overview

13. Company Profiles

  • 13.1 CMIC Holdings Co Ltd
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 EPS Holdings Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 IQVIA Holdings Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Syneos Health Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Mednext Pharmaceuticals Pvt Ltd
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Aenova Holding GmbH
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
  • 13.7 Pfizer Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms